Prothena Corp Public (PRTA) Non-Current Assets (2012 - 2026)

Prothena Corp Public's (PRTA) quarterly Non-Current Assets came in at $10.7 million in Q1 2026, down 81.93% year-on-year from $59.2 million in Q1 2025, and down 7.91% quarter-over-quarter from $11.6 million in Q4 2025.

Prothena Corp Public (PRTA) Non-Current Assets (2012 - 2026) Analysis & Trends

Prothena Corp Public's Non-Current Assets history runs 15 years deep, the most recent figure standing at $10.7 million for Q1 2026.

  • On a quarterly basis, Non-Current Assets fell 81.93% year-over-year to $10.7 million in Q1 2026; TTM through Mar 2026 was $10.7 million, a 81.93% decrease from a year earlier, with the FY2025 full-year figure at $11.6 million, down 81.18% from the prior year.
  • Non-Current Assets retreated to $10.7 million in Q1 2026 per PRTA's latest filing, from $11.6 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $61.7 million in Q4 2024 and bottomed at $10.7 million in Q1 2026.
  • The 5-year median for Non-Current Assets is $41.2 million (2023), against an average of $39.3 million.
  • Across the five-year window, Non-Current Assets surged 88.49% in 2023 and plunged 81.93% in 2026, its largest moves.
  • Year by year, Non-Current Assets stood at $38.9 million in 2022, then jumped by 46.65% to $57.1 million in 2023, then gained by 8.05% to $61.7 million in 2024, then sank by 81.18% to $11.6 million in 2025, then declined by 7.91% to $10.7 million in 2026.
  • Per Business Quant, the three latest PRTA Non-Current Assets figures stand at $10.7 million (Q1 2026), $11.6 million (Q4 2025), and $12.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 21.65 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 5.83 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 30.30 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.95 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - 289.41 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 285.82 Mn
10 Prothena Corp Public 467.80 Mn 138.33 Mn - 10.69 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.69 Mn
Dec 31, 2025 11.61 Mn
Sep 30, 2025 12.65 Mn
Jun 30, 2025 13.59 Mn
Mar 31, 2025 59.16 Mn
Dec 31, 2024 61.70 Mn
Sep 30, 2024 60.27 Mn
Jun 30, 2024 59.59 Mn
Mar 31, 2024 57.33 Mn
Dec 31, 2023 57.10 Mn
Sep 30, 2023 56.32 Mn
Jun 30, 2023 43.55 Mn
Mar 31, 2023 41.24 Mn
Dec 31, 2022 38.94 Mn
Sep 30, 2022 29.88 Mn
Jun 30, 2022 28.30 Mn
Mar 31, 2022 25.79 Mn
Dec 31, 2021 24.56 Mn
Sep 30, 2021 25.17 Mn
Jun 30, 2021 26.91 Mn